Microbot Medical Inc (MBOT) Stock Price, Quote & News

Company Profile

Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 781-875-3605

Website: microbotmedical.com

Address:

175 Derby Street, Bld. 27, Hingham, United States

eltimlang Sep. 8 at 9:59 AM

$MBOT Decision Date: 09/04/2025 Decision: Substantially Equivalent (SESE) https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K243789

0 · Reply

sldprt Sep. 8 at 9:56 AM

$MBOT Warrants are feasting. last chance to get in. when those are gone, no holding back.

1 · Reply

YouVSYou Sep. 8 at 9:51 AM

$MBOT

0 · Reply

mstan Sep. 8 at 9:50 AM

$MBOT 👍🤞

0 · Reply

bobbydoles Sep. 8 at 9:46 AM

$BBLG runs with $MBOT

0 · Reply

LennyVision Sep. 8 at 9:43 AM

$MBOT This post can age like milk, but is it real or fake so shorts can pump and dump? RE: FDA approval

1 · Reply

BigSqueezeComing Sep. 8 at 9:42 AM

$MBOT hot stocks

0 · Reply

AllenPei Sep. 8 at 9:36 AM

$MBOT "I’m out… stopped out at -11%, down $8,000."

1 · Reply

gladee88er Sep. 8 at 9:35 AM

$MBOT Right now it's running right below and parallel with anchored VWAP, so the shorts are in charge at the moment. Retail traders have to be patient or they get smoked. I know us longs that have been here awhile aren't worried a bit.

0 · Reply

HanTheLad Sep. 8 at 9:32 AM

$MBOT Why did it go down from 5$? Bruh

1 · Reply

Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst

Aug 20, 2025, 8:30 AM EDT - 18 days ago

Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications

Aug 5, 2025, 8:30 AM EDT - 4 weeks ago

Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities

Jul 22, 2025, 8:30 AM EDT - 6 weeks ago

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

Jul 8, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Jun 30, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical® Added to the Russell Microcap® Index

Jun 17, 2025, 8:30 AM EDT - 2 months ago

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China

Jun 9, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System

Jun 5, 2025, 8:30 AM EDT - 3 months ago

Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index

Apr 23, 2025, 8:30 AM EDT - 4 months ago

Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers

Apr 9, 2025, 8:30 AM EDT - 5 months ago

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

Apr 1, 2025, 8:30 AM EDT - 5 months ago

REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting

Mar 4, 2025, 8:30 AM EST - 6 months ago

Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System

Feb 25, 2025, 8:30 AM EST - 6 months ago

Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Feb 11, 2025, 6:15 PM EST - 7 months ago

Microbot Medical Closes $13 Million Registered Direct Offering

Feb 10, 2025, 8:00 AM EST - 7 months ago

Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jan 10, 2025, 10:25 AM EST - 8 months ago

Microbot Medical Closes $8.6 Million Registered Direct Offering

Jan 7, 2025, 4:15 PM EST - 8 months ago

Microbot Medical Raises a Total of Approximately $11.8 Million in Gross Proceeds from Registered Direct Offering and Previously Announced ATM Facility

Dec 30, 2024, 8:30 AM EST - 8 months ago

Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®

Dec 10, 2024, 10:18 AM EST - 9 months ago

Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access

Oct 15, 2024, 8:38 AM EDT - 11 months ago

Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025

Sep 30, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up

Sep 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System

Aug 22, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System

Aug 13, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

Jul 9, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial

Jul 8, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial

Jul 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial

Jun 20, 2024, 8:25 AM EDT - 1 year ago

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

Jun 17, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial

Jun 4, 2024, 4:20 PM EDT - 1 year ago

Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 12:11 PM EDT - 1 year ago

Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Jun 3, 2024, 8:20 AM EDT - 1 year ago

Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial

Apr 29, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Microbot Medical Shares Status Following Recent Geopolitical Events

Feb 5, 2024, 7:30 AM EST - 1 year ago

Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US

Jan 30, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters

Jan 18, 2024, 7:20 AM EST - 1 year ago

Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study

Dec 29, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules

Dec 28, 2023, 7:30 AM EST - 1 year ago

Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met

Dec 14, 2023, 8:15 AM EST - 1 year ago

Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic

Dec 7, 2023, 8:00 AM EST - 1 year ago

Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study

Nov 21, 2023, 9:12 AM EST - 1 year ago

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

Nov 13, 2023, 8:30 AM EST - 1 year ago

Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process

Nov 8, 2023, 9:10 AM EST - 1 year ago

Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office

Oct 31, 2023, 8:25 AM EDT - 2 years ago

Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study

Oct 24, 2023, 8:19 AM EDT - 2 years ago

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

Oct 19, 2023, 8:20 AM EDT - 2 years ago

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

eltimlang Sep. 8 at 9:59 AM

$MBOT Decision Date: 09/04/2025 Decision: Substantially Equivalent (SESE) https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K243789

0 · Reply

sldprt Sep. 8 at 9:56 AM

$MBOT Warrants are feasting. last chance to get in. when those are gone, no holding back.

1 · Reply

YouVSYou Sep. 8 at 9:51 AM

$MBOT

0 · Reply

mstan Sep. 8 at 9:50 AM

$MBOT 👍🤞

0 · Reply

bobbydoles Sep. 8 at 9:46 AM

$BBLG runs with $MBOT

0 · Reply

LennyVision Sep. 8 at 9:43 AM

$MBOT This post can age like milk, but is it real or fake so shorts can pump and dump? RE: FDA approval

1 · Reply

BigSqueezeComing Sep. 8 at 9:42 AM

$MBOT hot stocks

0 · Reply

AllenPei Sep. 8 at 9:36 AM

$MBOT "I’m out… stopped out at -11%, down $8,000."

1 · Reply

gladee88er Sep. 8 at 9:35 AM

0 · Reply

HanTheLad Sep. 8 at 9:32 AM

$MBOT Why did it go down from 5$? Bruh

1 · Reply

Dreamer89 Sep. 8 at 9:32 AM

$MBOT this mbot actually had FDA news but instead of running this 100%, these Nasdaq donkeys instead spiked random no news tickers like OCTO and Ford 100% each. 😱😂🐖🐖🐖🐖✂️✂️✂️✂️✂️✂️

0 · Reply

sldprt Sep. 8 at 9:26 AM

$MBOT I know they are out there, and I know they like to have fun. Like pushing CIMG to 666% and then going home. Come and play with our shorts please and thank you. I am holding long term and would enjoy it if you would visit me on my day!

0 · Reply

Loren77 Sep. 8 at 9:25 AM

$MBOT

0 · Reply

aletz Sep. 8 at 9:25 AM

$MBOT Grab more and hold if you want the SP to move up. Good luck!

0 · Reply

Ahsgdg Sep. 8 at 9:09 AM

$MBOT 4.7 and its this early in premarket... get ready for the ride up, bc once people wake up. This thing is gking crazy

0 · Reply

zo_man Sep. 8 at 9:05 AM

$MBOT If you are a RETAIL short. Implore you to be careful with this stock. You have no idea what’s going to happen here. This is not your pump & dump play. Only invest as much as you can afford to loose.

3 · Reply

gladee88er Sep. 8 at 9:05 AM

$MBOT Be prepared they will bring it down to shake out the short-timers.

0 · Reply

mOTCallouts Sep. 8 at 9:00 AM

$MBOT this dip got eaten up quick.

0 · Reply

the_viking Sep. 8 at 8:58 AM

$MBOT Well lets see... if its like all FDA news on Biostocks, we will close red today:) ... I´m not a shorter, but my trust is gone in this market... I bought last week and sold 80% of my holdings today at the +40% spike... let´s see what happens with my other 20%.

2 · Reply

Eghanm6227 Sep. 8 at 8:55 AM

$MBOT $ZNB

0 · Reply

voiceRobot Sep. 8 at 8:54 AM

$MBOT When will the official news be released? I'm going to fly away when the official news comes out.

0 · Reply

Joeyoliv Sep. 8 at 8:54 AM

$MBOT and the news hasn't been released yet. Imagine when it starts circulating 🚀🚀 lets gooo

0 · Reply

Market Cap	166.70M
Revenue (ttm)	0.00
Net Income (ttm)	-11.44M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,350,600
Avg Vol	2,402,928
Day's Range	N/A - N/A
Shares Out	45.55M
Stochastic %K	31%
Beta	1.22
Analysts	Sell
Price Target	$9.00